Skip to main content
Top
Published in: BMC Endocrine Disorders 1/2023

Open Access 01-12-2023 | Insulins | Research

Early-induced diabetic obese rat MACAPOS 2

Authors: Joseph Ngakou Mukam, Clémence Mvongo, Sandrine Nkoubat, Gaëtan Olivier Fankem, Adamou Mfopa, Paul Aimé Noubissi, Michel Archange Fokam Tagne, René Kamgang, Jean-Louis Essame Oyono

Published in: BMC Endocrine Disorders | Issue 1/2023

Login to get access

Abstract

Background

Diabetes mellitus is a metabolic disease characterized by an abnormally high blood glucose level. Glucose intolerance and insulin resistance are two characteristics that promote the onset and development of type 2 diabetes. The aim of this study was to create a diabetic rat model from obese rat MACAPOS 2.

Methods

A group of rats was subjected to a high-fat diet (HFD) compared to a control group (NC) which received a normal diet. After 16 weeks of HFD, Lee index was calculated, obese rats were subjected to an oral glucose tolerance test (OGTT) and insulin tolerance test (ITT). One group of HFD rats (HFDZ) received streptozotocin 22.5 mg/kg (iv). One week later, weight gain, water and food intakes, urine volume and fasting blood glucose levels were evaluated. Animals were also subjected to glucose tolerance and insulin tolerance tests.

Results

After 16 weeks of HFD, rats became obese, glucose intolerant and resistant to insulin. The body weight of rats was significantly high (+ 26.23%) compared to normal rats, glycemia remained significantly high (+ 45.46%, P < 0.01) two hours after administration of glucose in high-fat diet rats, water intake and urine volume were comparable to those of NC. In HFD, the streptozotocin injected after one week (HFDZ), amplified glucose intolerance. During ITT, glycemia remained significantly (P < 0.01) high from 15 min; and did not vary during the 60 min of ITT. The fasting glycemia one week after streptozotocin injection was significantly high (288 mg/dL) compared to HFD (114 mg/dL), associated whit a significant (P < 0.01) increase in water intake and 24 h urine volume.

Conclusion

These results showed that MACAPOS 2 associated with a low dose of streptozotocin (22.5 mg/dL) early leads to the diabetes in obese albinos Wistar rats and could be a real model to study the type 2 diabetes mellitus.
Literature
1.
go back to reference American Diabetes Association (ADA). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014;37(1):81–90.CrossRef American Diabetes Association (ADA). Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014;37(1):81–90.CrossRef
2.
go back to reference Word Hearth Organization (WHO). Classification of diabetes mellitus. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO Word Hearth Organization (WHO). Classification of diabetes mellitus. Geneva: World Health Organization; 2019. Licence: CC BY-NC-SA 3.0 IGO
3.
go back to reference Ankur R, Shahjad A. Alloxan Induced Diabetes: Mechanisms and Effects. Int J Res Pharm Biomed Sci. 2012;3(2):819–23. Ankur R, Shahjad A. Alloxan Induced Diabetes: Mechanisms and Effects. Int J Res Pharm Biomed Sci. 2012;3(2):819–23.
4.
go back to reference Kottaisamy Chidhambara PD, Raj Divya S, Prasanth Kumar V, Sankaran U. Experimental animal models for diabetes and its related complications-a review. Lab Anim Res. 2021;37(23):1–14. Kottaisamy Chidhambara PD, Raj Divya S, Prasanth Kumar V, Sankaran U. Experimental animal models for diabetes and its related complications-a review. Lab Anim Res. 2021;37(23):1–14.
5.
go back to reference Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1(78):1–21. Furman BL. Streptozotocin-induced diabetic models in mice and rats. Curr Protoc. 2021;1(78):1–21.
6.
go back to reference Kaku K. Pathophysiology of Type 2 Diabetes and Its Treatment Policy. J Japan Med Assoc. 2010;53(1):41–6. Kaku K. Pathophysiology of Type 2 Diabetes and Its Treatment Policy. J Japan Med Assoc. 2010;53(1):41–6.
7.
go back to reference Adamou M, Mediesse Francine K, Clémence M, Sandrine NC, Lum Ambe A, Eugène S, et al. Antidyslipidemic Potential of Water-Soluble Polysaccharides of Ganoderma applanatum in MACAPOS-2-Induced Obese Rats. Evid Based Complementary Altern Med. 2021;2021:1–9. Adamou M, Mediesse Francine K, Clémence M, Sandrine NC, Lum Ambe A, Eugène S, et al. Antidyslipidemic Potential of Water-Soluble Polysaccharides of Ganoderma applanatum in MACAPOS-2-Induced Obese Rats. Evid Based Complementary Altern Med. 2021;2021:1–9.
8.
go back to reference Kamgang R, Youmbi R, Mengue GP, Ngogang Y. Cameroon local-diet induced glucose intolerance and dyslipidemia in adult Wistar Rat. Diabetes Rese Clin Pract. 2005;69:224–30.CrossRef Kamgang R, Youmbi R, Mengue GP, Ngogang Y. Cameroon local-diet induced glucose intolerance and dyslipidemia in adult Wistar Rat. Diabetes Rese Clin Pract. 2005;69:224–30.CrossRef
9.
go back to reference Mvongo C, Kamgang R, Minka Minka CS, Mfopa A, Essame Oyono JL. Effect of ethanol-water extract of Crinum jagus on glycemia reactivity in dexamethasone-induced diabetic rat macapos 1. Int J Pharma Res Bio Sci. 2014;3(6):157–67. Mvongo C, Kamgang R, Minka Minka CS, Mfopa A, Essame Oyono JL. Effect of ethanol-water extract of Crinum jagus on glycemia reactivity in dexamethasone-induced diabetic rat macapos 1. Int J Pharma Res Bio Sci. 2014;3(6):157–67.
10.
go back to reference Li W, Minjie W, Hengguang Z, Pufu L, Baosha T, Junchen C, et al. Hypoglycemic effect of okra aqueous extract on streptozotocin-induced diabetic rats. Food Sci Technol. 2020;40(4):972–8.CrossRef Li W, Minjie W, Hengguang Z, Pufu L, Baosha T, Junchen C, et al. Hypoglycemic effect of okra aqueous extract on streptozotocin-induced diabetic rats. Food Sci Technol. 2020;40(4):972–8.CrossRef
11.
go back to reference Correia-Santos AM, Suzuki A, Anjos JS, Rêgo TS, KCl A, Boaventura GT. Induction of Type 2 Diabetes by low dose of streptozotocin and high-fat diet-fed in wistar rats. Medicina (Ribeirão Preto). 2012;45(4):436–44.CrossRef Correia-Santos AM, Suzuki A, Anjos JS, Rêgo TS, KCl A, Boaventura GT. Induction of Type 2 Diabetes by low dose of streptozotocin and high-fat diet-fed in wistar rats. Medicina (Ribeirão Preto). 2012;45(4):436–44.CrossRef
12.
go back to reference Diego De Magalhães A, Kume Willian T, Correia Francyele S, Queiroz Thaís S, Allebrandt Neto Edgar W, Dos Santos MP, et al. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. Ana Acad Bras Cien. 2019;91(1):e20180314.CrossRef Diego De Magalhães A, Kume Willian T, Correia Francyele S, Queiroz Thaís S, Allebrandt Neto Edgar W, Dos Santos MP, et al. High-fat diet and streptozotocin in the induction of type 2 diabetes mellitus: a new proposal. Ana Acad Bras Cien. 2019;91(1):e20180314.CrossRef
13.
go back to reference Smith J, van den Broek F, Martorel J, Hackbarth H, Ruksenas O, Zeller W. FELASA Working Grp, and Principles and Practice in Ethical Review of Animal Experiments across Europe: Summary of the Report of a Felasa Working Group on Ethical Evaluation of Animal Experiments. Lab Anim. 2007;41:143–60.CrossRefPubMed Smith J, van den Broek F, Martorel J, Hackbarth H, Ruksenas O, Zeller W. FELASA Working Grp, and Principles and Practice in Ethical Review of Animal Experiments across Europe: Summary of the Report of a Felasa Working Group on Ethical Evaluation of Animal Experiments. Lab Anim. 2007;41:143–60.CrossRefPubMed
14.
go back to reference Nya JGBS, Kamgang R, Nkomo Soua PR, Essame Oyono JL, Njikam N. Effect of methanol/methylene chloride extract of Terminalia glaucescens leaves on normal mice. Asian J Pharm Clin Res. 2008;1:54–9. Nya JGBS, Kamgang R, Nkomo Soua PR, Essame Oyono JL, Njikam N. Effect of methanol/methylene chloride extract of Terminalia glaucescens leaves on normal mice. Asian J Pharm Clin Res. 2008;1:54–9.
15.
go back to reference Vatandoust N, Rami F, Salehi AR, Khosravi S, Dashti G, Eslami G, et al. Novel High-Fat Diet Formulation and Streptozotocin Treatment for Induction of Prediabetes and Type 2 Diabetes in Rats. Adv Biomed Res. 2018;7:1–5. Vatandoust N, Rami F, Salehi AR, Khosravi S, Dashti G, Eslami G, et al. Novel High-Fat Diet Formulation and Streptozotocin Treatment for Induction of Prediabetes and Type 2 Diabetes in Rats. Adv Biomed Res. 2018;7:1–5.
16.
go back to reference Gary LD. Fatty acid oxidation and its relation with insulin resistance and associated disorders. Ann Nutr Metab. 2016;68(3):15–20. Gary LD. Fatty acid oxidation and its relation with insulin resistance and associated disorders. Ann Nutr Metab. 2016;68(3):15–20.
17.
go back to reference Scheen AJ. Le concept d’insulinosensibilité. Diabète Métab. 2001;27:193–200.PubMed Scheen AJ. Le concept d’insulinosensibilité. Diabète Métab. 2001;27:193–200.PubMed
18.
go back to reference Cazzolli R, Craig DL, Biden TJ, Schmitz PC. Inhibition of glycogen synthesis by fatty acid in C2C12muscle cells is independent of PKC-α, -ε, and -θ. Am J Physiol Endocrinol Metab. 2002;282:E1204–13.CrossRefPubMed Cazzolli R, Craig DL, Biden TJ, Schmitz PC. Inhibition of glycogen synthesis by fatty acid in C2C12muscle cells is independent of PKC-α, -ε, and -θ. Am J Physiol Endocrinol Metab. 2002;282:E1204–13.CrossRefPubMed
19.
go back to reference Jeevendra Martyn JA, Masao K, Shingo Y. Obesity-Induced Insulin Resistance and Hyperglycemia: Etiological Factors and Molecular Mechanisms. Anesthesiology. 2008;109(1):137–48.CrossRef Jeevendra Martyn JA, Masao K, Shingo Y. Obesity-Induced Insulin Resistance and Hyperglycemia: Etiological Factors and Molecular Mechanisms. Anesthesiology. 2008;109(1):137–48.CrossRef
20.
go back to reference Jianping Y. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24.CrossRef Jianping Y. Mechanisms of insulin resistance in obesity. Front Med. 2013;7(1):14–24.CrossRef
22.
go back to reference Spinas GA, Lehmann R. Diabète sucré : Diagnostic, classification et pathogenèse. Forum Med Suisse. 2001;20:519–25. Spinas GA, Lehmann R. Diabète sucré : Diagnostic, classification et pathogenèse. Forum Med Suisse. 2001;20:519–25.
23.
go back to reference Coelho DF, Pereira-Lancha LO, Chaves DS, Diwan D, Ferraz R, Campos-Ferraz PL, et al. Effect of high-fat diets on body composition, lipid metabolism and insulin sensitivity, and the role of exercise on these parameters. Braz J Med Biol Res. 2011;44(10):966–72.CrossRefPubMed Coelho DF, Pereira-Lancha LO, Chaves DS, Diwan D, Ferraz R, Campos-Ferraz PL, et al. Effect of high-fat diets on body composition, lipid metabolism and insulin sensitivity, and the role of exercise on these parameters. Braz J Med Biol Res. 2011;44(10):966–72.CrossRefPubMed
24.
go back to reference Kamgang R, Youmbi Mboumi R, Foyet Fondjo A, Fokam Tagne MA, Mengue Ndille GPR, Ngogang YJ. Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae). J Nat Med. 2008;62:34–40.CrossRefPubMed Kamgang R, Youmbi Mboumi R, Foyet Fondjo A, Fokam Tagne MA, Mengue Ndille GPR, Ngogang YJ. Antihyperglycaemic potential of the water-ethanol extract of Kalanchoe crenata (Crassulaceae). J Nat Med. 2008;62:34–40.CrossRefPubMed
25.
go back to reference Liu RM, Dai R, Luo Y, Xiao JH. Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice. BMC Complement Altern Med. 2019;19(230):10. Liu RM, Dai R, Luo Y, Xiao JH. Glucose-lowering and hypolipidemic activities of polysaccharides from Cordyceps taii in streptozotocin-induced diabetic mice. BMC Complement Altern Med. 2019;19(230):10.
26.
go back to reference Kiss ACI, Lima PHO, Sinzato YK, Takaku M, Takeno MA, Rudge MVC, et al. Animal models for clinical and gestational diabetes: maternal and fetal outcomes. Diabetol Metab Syndr. 2009;1:1–7.CrossRef Kiss ACI, Lima PHO, Sinzato YK, Takaku M, Takeno MA, Rudge MVC, et al. Animal models for clinical and gestational diabetes: maternal and fetal outcomes. Diabetol Metab Syndr. 2009;1:1–7.CrossRef
27.
go back to reference Silvia MF, Marta GR, Gema V, Astier J, Landrier JF, Marta M. High Fat/High Glucose Diet Induces Metabolic Syndrome in an Experimental Rat Model. Nutrients. 2018;10(1502):1–15. Silvia MF, Marta GR, Gema V, Astier J, Landrier JF, Marta M. High Fat/High Glucose Diet Induces Metabolic Syndrome in an Experimental Rat Model. Nutrients. 2018;10(1502):1–15.
28.
go back to reference Zafar M, et Naeem-ul-hassan NS. Effects of STZ-Induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol. 2010;28(1):135–42.CrossRef Zafar M, et Naeem-ul-hassan NS. Effects of STZ-Induced diabetes on the relative weights of kidney, liver and pancreas in albino rats: a comparative study. Int J Morphol. 2010;28(1):135–42.CrossRef
29.
go back to reference Hyun-Jong S, Jae-Ha K, Joo-Hark Y, Sang-Woong H, Ho-Jung K. Polyuria with the Concurrent manifestation of Central Diabetes Insipidus (CDI) & Type 2 Diabetes Mellitus (DM). Electrolyte Blood Press. 2012;10:26–30.CrossRef Hyun-Jong S, Jae-Ha K, Joo-Hark Y, Sang-Woong H, Ho-Jung K. Polyuria with the Concurrent manifestation of Central Diabetes Insipidus (CDI) & Type 2 Diabetes Mellitus (DM). Electrolyte Blood Press. 2012;10:26–30.CrossRef
Metadata
Title
Early-induced diabetic obese rat MACAPOS 2
Authors
Joseph Ngakou Mukam
Clémence Mvongo
Sandrine Nkoubat
Gaëtan Olivier Fankem
Adamou Mfopa
Paul Aimé Noubissi
Michel Archange Fokam Tagne
René Kamgang
Jean-Louis Essame Oyono
Publication date
01-12-2023
Publisher
BioMed Central
Published in
BMC Endocrine Disorders / Issue 1/2023
Electronic ISSN: 1472-6823
DOI
https://doi.org/10.1186/s12902-022-01252-8

Other articles of this Issue 1/2023

BMC Endocrine Disorders 1/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.